Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Journal of Immunological Methods|October 13, 2005
IgG subclass-independent improvement of antibody-dependent cellular cytotoxicity by fucose removal from Asn297-linked oligosaccharidesRinpei Niwa, Akito Natsume, Aya Uehara, et al.
Protein Science : a Publication of the Protein Society|October 22, 2025
Immunoglobulin G Fc engineering for localized therapy: Eliminating neonatal Fc receptor interactions and ensuring purification using protein AAkifumi Kato, Asami Toshima, Gennosuke Takekawa, et al.
Journal of Biochemistry|July 25, 2006
Fucose removal from complex-type oligosaccharide enhances the antibody-dependent cellular cytotoxicity of single-gene-encoded bispecific antibody comprising of two single-chain antibodies linked to the antibody constant regionAkito Natsume, Masako Wakitani, Naoko Yamane-Ohnuki, et al.
Journal of Immunological Methods|October 21, 2005
Fucose removal from complex-type oligosaccharide enhances the antibody-dependent cellular cytotoxicity of single-gene-encoded antibody comprising a single-chain antibody linked the antibody constant regionAkito Natsume, Masako Wakitani, Naoko Yamane-Ohnuki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2004
Enhancement of the antibody-dependent cellular cytotoxicity of low-fucose IgG1 Is independent of FcgammaRIIIa functional polymorphismRinpei Niwa, Shigeki Hatanaka, Emi Shoji-Hosaka, et al.
Cancer Research|May 17, 2008
Engineered antibodies of IgG1/IgG3 mixed isotype with enhanced cytotoxic activitiesAkito Natsume, Mika In, Hiroyuki Takamura, et al.
Cancer Research|March 18, 2004
Defucosylated chimeric anti-CC chemokine receptor 4 IgG1 with enhanced antibody-dependent cellular cytotoxicity shows potent therapeutic activity to T-cell leukemia and lymphomaRinpei Niwa, Emi Shoji-Hosaka, Mikiko Sakurada, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2007
A nonfucosylated anti-HER2 antibody augments antibody-dependent cellular cytotoxicity in breast cancer patientsEiji Suzuki, Rinpei Niwa, Shigehira Saji, et al.
Anticancer Research|January 10, 2014
The therapeutic potential of a novel PSMA antibody and its IL-2 conjugate in prostate cancerYoshiyuki Sugimoto, Maiko Hirota, Kazuhiro Yoshikawa, et al.
Biotechnology and Bioengineering|September 8, 2004
Establishment of FUT8 knockout Chinese hamster ovary cells: an ideal host cell line for producing completely defucosylated antibodies with enhanced antibody-dependent cellular cytotoxicityNaoko Yamane-Ohnuki, Satoko Kinoshita, Miho Inoue-Urakubo, et al.
Pageof 3